Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantin V Balakin

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Expert Opinion on Investigational Drugs|December 13, 2006
VEGF/VEGFR signalling as a target for inhibiting angiogenesisAlex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko
Current Opinion in Chemical Biology|August 4, 2004
Exploring the chemogenomic knowledge space with annotated chemical librariesNikolay P Savchuk, Konstantin V Balakin, Sergey E Tkachenko
Current Medicinal Chemistry|February 14, 2006
In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutionsKonstantin V Balakin, Nikolay P Savchuk, Igor V Tetko
Journal of Medicinal Chemistry|August 18, 2006
Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniquesSean Ekins, Konstantin V Balakin, Nikolay Savchuk, et al.
Drug Discovery Today|June 13, 2009
Computational mapping tools for drug discoveryYan A Ivanenkov, Nikolay P Savchuk, Sean Ekins, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 9, 2008
Caspase activity modulators as anticancer agentsIlya Okun, Konstantin V Balakin, Sergey E Tkachenko, et al.
Mini Reviews in Medicinal Chemistry|June 22, 2006
Recent progress in development of non-ATP competitive small-molecule inhibitors of protein kinasesAlex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko, et al.
Expert Opinion on Therapeutic Targets|August 2, 2007
Small-molecule modulators of Hh and Wnt signaling pathwaysAlex S Kiselyov, Sergey E Tkachenko, Konstantin V Balakin, et al.
Current Drug Discovery Technologies|May 23, 2006
Rational design approaches to chemical libraries for hit identificationKonstantin V Balakin, Alexander V Kozintsev, Alex S Kiselyov, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2007
Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspectiveKonstantin V Balakin, Yan A Ivanenkov, Alex S Kiselyov, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|December 13, 2006
VEGF/VEGFR signalling as a target for inhibiting angiogenesisAlex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko
Current Opinion in Chemical Biology|August 4, 2004
Exploring the chemogenomic knowledge space with annotated chemical librariesNikolay P Savchuk, Konstantin V Balakin, Sergey E Tkachenko
Current Medicinal Chemistry|February 14, 2006
In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutionsKonstantin V Balakin, Nikolay P Savchuk, Igor V Tetko
Journal of Medicinal Chemistry|August 18, 2006
Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniquesSean Ekins, Konstantin V Balakin, Nikolay Savchuk, et al.
Drug Discovery Today|June 13, 2009
Computational mapping tools for drug discoveryYan A Ivanenkov, Nikolay P Savchuk, Sean Ekins, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 9, 2008
Caspase activity modulators as anticancer agentsIlya Okun, Konstantin V Balakin, Sergey E Tkachenko, et al.
Mini Reviews in Medicinal Chemistry|June 22, 2006
Recent progress in development of non-ATP competitive small-molecule inhibitors of protein kinasesAlex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko, et al.
Expert Opinion on Therapeutic Targets|August 2, 2007
Small-molecule modulators of Hh and Wnt signaling pathwaysAlex S Kiselyov, Sergey E Tkachenko, Konstantin V Balakin, et al.
Current Drug Discovery Technologies|May 23, 2006
Rational design approaches to chemical libraries for hit identificationKonstantin V Balakin, Alexander V Kozintsev, Alex S Kiselyov, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2007
Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspectiveKonstantin V Balakin, Yan A Ivanenkov, Alex S Kiselyov, et al.
Pageof 5